Three New Keytruda Indications Among Mid-October Approvals By PacConAdmin | October 17, 2023 | 0 The FDA handed out a fistful of approvals this week, including three for Merck’s juggernaut PD-1 blocker Keytruda, bringing the drug’s total indications to 36. Source: Drug Industry Daily Posted in Uncategorized and tagged aaps